196
Participants
Start Date
September 30, 2009
Primary Completion Date
January 31, 2015
Study Completion Date
December 31, 2023
Sarcoma and GIST
No Intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy.
Breast cancer
No intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy.
Pancreatic cancer
No intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy.
Renal cell carcinoma
No intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy.
Colon cancer
No intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy (adjuvant setting).
Solid tumours undergoing image-guided tumor ablation
No intervention : Consensus of international experts to provide definition of survival endpoints to be used in randomized controlled trials to assess treatment efficacy.
Institut Bergonié, Bordeaux
Centre Georges François Leclerc, Dijon
Institut du Cancer de Montpellier, Montpellier
Lead Sponsor
National Cancer Institute, France
OTHER_GOV
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER
Centre Georges Francois Leclerc
OTHER
Institut Bergonié
OTHER